Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
The Lancet. Respiratory Medicine|May 27, 2017
Benralizumab for patients with mild to moderate, persistent asthma (BISE): a randomised, double-blind, placebo-controlled, phase 3 trialGary T Ferguson, J Mark FitzGerald, Eugene R Bleecker, et al.
NMR in Biomedicine|September 18, 2020
Spectral editing in 1 H magnetic resonance spectroscopy: Experts' consensus recommendationsIn-Young Choi, Ovidiu C Andronesi, Peter Barker, et al.
The Lancet. Respiratory Medicine|October 3, 2019
Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studiesGerard J Criner, Bartolome R Celli, Dave Singh, et al.
Magnetic Resonance in Medicine|July 5, 2020
Fast whole brain MR imaging of dynamic susceptibility contrast changes in the cerebrospinal fluid (cDSC MRI)Di Cao, Ningdong Kang, Jay J Pillai, et al.
The Journal of Clinical Endocrinology and Metabolism|June 4, 2018
Frequent Monitoring of C-Peptide Levels in Newly Diagnosed Type 1 Subjects Using Dried Blood Spots Collected at HomeRuben H Willemsen, Keith Burling, Peter Barker, et al.
Cancer Chemotherapy and Pharmacology|January 23, 2014
Phase I dose-escalation study of AZD7762, a checkpoint kinase inhibitor, in combination with gemcitabine in US patients with advanced solid tumorsEdward Sausville, Patricia Lorusso, Michael Carducci, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 23, 2018
Abemaciclib Is Active in Preclinical Models of Ewing Sarcoma via Multipronged Regulation of Cell Cycle, DNA Methylation, and Interferon Pathway SignalingMichele Dowless, Caitlin D Lowery, Terry Shackleford, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 21, 2019
Two-year integrated steroid-sparing analysis and safety of benralizumab for severe asthmaArnaud Bourdin, Dominick Shaw, Andrew Menzies-Gow, et al.
Pageof 8